News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Cell Therapy Manufacturing sign new agreementCell Therapy Manufacturing sign new agreementNew company created to develop novel technology to treat diabetesNew company created to develop novel technology to treat diabetesNew report shows that capacity and capability in cell and gene therapy manufacturing continues to increase in the UKNew report shows that capacity and capability in cell and gene therapy manufacturing continues to increase in the UKCell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesFrameworks for promising therapies with less mature evidence base to secure adoptionFrameworks for promising therapies with less mature evidence base to secure adoptionCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell Therapy Catapult is now the Cell and Gene Therapy CatapultCell Therapy Catapult is now the Cell and Gene Therapy CatapultReNeuron wins major UK grant to advance its exosome nanomedicine platformReNeuron wins major UK grant to advance its exosome nanomedicine platformSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell linesSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell linesCell Therapy Catapult, University of Birmingham and Cancer Research Technology launch new collaboration for CAR-T cell immuno-oncology therapy developmentCell Therapy Catapult, University of Birmingham and Cancer Research Technology launch new collaboration for CAR-T cell immuno-oncology therapy developmentHorizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trialHorizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trial